AAPL353.11+21.21 (+6.39%) ▲|ABBV285.72-0.28 (-0.10%) ▼|ABT114.57+5.17 (+4.73%) ▲|ACN265.25+10.69 (+4.20%) ▲|ADBE252.87+6.73 (+2.73%) ▲|AMAT370.29-11.63 (-3.05%) ▼|AMD486.66+2.76 (+0.57%) ▲|AMGN473.30+12.04 (+2.61%) ▲|AMT195.14+7.85 (+4.19%) ▲|AMZN266.71+16.02 (+6.39%) ▲|AVGO326.33-5.80 (-1.75%) ▼|AXP331.89+6.39 (+1.96%) ▲|BA176.92+3.61 (+2.08%) ▲|BAC51.57+1.91 (+3.85%) ▲|BKNG172.39+16.72 (+10.74%) ▲|BLK1,216.59+55.27 (+4.76%) ▲|BMY63.02+1.31 (+2.12%) ▲|BNY149.93+0.62 (+0.41%) ▲|BRK-B572.73+15.66 (+2.81%) ▲|C125.21+2.50 (+2.04%) ▲|CAT583.50-40.44 (-6.48%) ▼|CL99.32+3.70 (+3.87%) ▲|CMCSA24.91+1.24 (+5.22%) ▲|COF203.97-4.75 (-2.27%) ▼|COP137.90-6.50 (-4.50%) ▼|COST1,050.06+30.80 (+3.02%) ▲|CRM228.20+6.00 (+2.70%) ▲|CSCO102.61-0.36 (-0.35%) ▼|CVS81.22-10.19 (-11.15%) ▼|CVX217.92-7.35 (-3.26%) ▼|DE662.93-2.90 (-0.44%) ▼|DHR232.12+2.01 (+0.87%) ▲|DIS119.86+5.68 (+4.97%) ▲|DUK129.64+3.13 (+2.47%) ▲|EMR168.37+1.98 (+1.19%) ▲|FDX322.80+4.78 (+1.50%) ▲|GD363.39-11.11 (-2.97%) ▼|GE323.01+2.34 (+0.73%) ▲|GEV812.57-105.64 (-11.50%) ▼|GILD173.37+5.90 (+3.52%) ▲|GM93.09+4.75 (+5.38%) ▲|GOOG289.52+11.25 (+4.04%) ▲|GOOGL291.28+11.25 (+4.02%) ▲|GS917.09+21.00 (+2.34%) ▲|HD349.60+15.94 (+4.78%) ▲|HON226.45+2.40 (+1.07%) ▲|IBM256.19+6.15 (+2.46%) ▲|INTC57.56-3.00 (-4.95%) ▼|INTU361.98+17.26 (+5.01%) ▲|ISRG482.60+41.85 (+9.50%) ▲|JNJ272.93+6.76 (+2.54%) ▲|JPM349.84+11.86 (+3.51%) ▲|KO96.17+1.37 (+1.44%) ▲|LIN523.87+12.32 (+2.41%) ▲|LLY1,431.00+21.62 (+1.53%) ▲|LMT598.56-40.44 (-6.33%) ▼|LOW227.36+13.98 (+6.55%) ▲|LRCX225.05-5.67 (-2.46%) ▼|MA669.09+21.91 (+3.39%) ▲|MCD276.90+13.86 (+5.27%) ▲|MDLZ67.85+2.73 (+4.19%) ▲|MDT104.45+5.57 (+5.63%) ▲|META629.26+8.23 (+1.33%) ▲|MMM192.08+15.03 (+8.49%) ▲|MO78.42+1.48 (+1.92%) ▲|MRK148.47+3.80 (+2.63%) ▲|MS191.00+4.91 (+2.64%) ▲|MSFT553.68+32.69 (+6.27%) ▲|MU804.52-50.58 (-5.92%) ▼|NEE88.10+3.77 (+4.47%) ▲|NFLX66.07+2.65 (+4.17%) ▲|NKE40.67+2.19 (+5.68%) ▲|NOW109.90+0.74 (+0.68%) ▲|NVDA202.58-4.11 (-1.99%) ▼|ORCL125.60-0.59 (-0.47%) ▼|PEP143.51+6.24 (+4.55%) ▲|PFE30.52+0.52 (+1.73%) ▲|PG167.56+5.50 (+3.39%) ▲|PLTR171.38-4.02 (-2.29%) ▼|PM211.56+3.53 (+1.70%) ▲|QCOM165.57+1.14 (+0.69%) ▲|RTX195.21-8.61 (-4.22%) ▼|SBUX108.67+3.90 (+3.72%) ▲|SCHW92.63+3.35 (+3.75%) ▲|SO92.27-1.48 (-1.58%) ▼|SPG227.15+5.07 (+2.28%) ▲|T22.00+0.61 (+2.83%) ▲|TMO701.50+3.16 (+0.45%) ▲|TMUS160.11+5.70 (+3.69%) ▲|TSLA382.71-15.79 (-3.96%) ▼|TXN308.07-4.42 (-1.41%) ▼|UBER71.43+4.83 (+7.25%) ▲|UNH404.65+0.21 (+0.05%) ▲|UNP305.39+1.96 (+0.64%) ▲|UPS113.61+4.44 (+4.06%) ▲|USB60.50+0.61 (+1.02%) ▲|V432.75+12.33 (+2.93%) ▲|VZ46.41+1.17 (+2.58%) ▲|WFC86.69+1.16 (+1.35%) ▲|WMT130.01+5.15 (+4.12%) ▲|XOM170.81-6.66 (-3.75%) ▼|AAPL353.11+21.21 (+6.39%) ▲|ABBV285.72-0.28 (-0.10%) ▼|ABT114.57+5.17 (+4.73%) ▲|ACN265.25+10.69 (+4.20%) ▲|ADBE252.87+6.73 (+2.73%) ▲|AMAT370.29-11.63 (-3.05%) ▼|AMD486.66+2.76 (+0.57%) ▲|AMGN473.30+12.04 (+2.61%) ▲|AMT195.14+7.85 (+4.19%) ▲|AMZN266.71+16.02 (+6.39%) ▲|AVGO326.33-5.80 (-1.75%) ▼|AXP331.89+6.39 (+1.96%) ▲|BA176.92+3.61 (+2.08%) ▲|BAC51.57+1.91 (+3.85%) ▲|BKNG172.39+16.72 (+10.74%) ▲|BLK1,216.59+55.27 (+4.76%) ▲|BMY63.02+1.31 (+2.12%) ▲|BNY149.93+0.62 (+0.41%) ▲|BRK-B572.73+15.66 (+2.81%) ▲|C125.21+2.50 (+2.04%) ▲|CAT583.50-40.44 (-6.48%) ▼|CL99.32+3.70 (+3.87%) ▲|CMCSA24.91+1.24 (+5.22%) ▲|COF203.97-4.75 (-2.27%) ▼|COP137.90-6.50 (-4.50%) ▼|COST1,050.06+30.80 (+3.02%) ▲|CRM228.20+6.00 (+2.70%) ▲|CSCO102.61-0.36 (-0.35%) ▼|CVS81.22-10.19 (-11.15%) ▼|CVX217.92-7.35 (-3.26%) ▼|DE662.93-2.90 (-0.44%) ▼|DHR232.12+2.01 (+0.87%) ▲|DIS119.86+5.68 (+4.97%) ▲|DUK129.64+3.13 (+2.47%) ▲|EMR168.37+1.98 (+1.19%) ▲|FDX322.80+4.78 (+1.50%) ▲|GD363.39-11.11 (-2.97%) ▼|GE323.01+2.34 (+0.73%) ▲|GEV812.57-105.64 (-11.50%) ▼|GILD173.37+5.90 (+3.52%) ▲|GM93.09+4.75 (+5.38%) ▲|GOOG289.52+11.25 (+4.04%) ▲|GOOGL291.28+11.25 (+4.02%) ▲|GS917.09+21.00 (+2.34%) ▲|HD349.60+15.94 (+4.78%) ▲|HON226.45+2.40 (+1.07%) ▲|IBM256.19+6.15 (+2.46%) ▲|INTC57.56-3.00 (-4.95%) ▼|INTU361.98+17.26 (+5.01%) ▲|ISRG482.60+41.85 (+9.50%) ▲|JNJ272.93+6.76 (+2.54%) ▲|JPM349.84+11.86 (+3.51%) ▲|KO96.17+1.37 (+1.44%) ▲|LIN523.87+12.32 (+2.41%) ▲|LLY1,431.00+21.62 (+1.53%) ▲|LMT598.56-40.44 (-6.33%) ▼|LOW227.36+13.98 (+6.55%) ▲|LRCX225.05-5.67 (-2.46%) ▼|MA669.09+21.91 (+3.39%) ▲|MCD276.90+13.86 (+5.27%) ▲|MDLZ67.85+2.73 (+4.19%) ▲|MDT104.45+5.57 (+5.63%) ▲|META629.26+8.23 (+1.33%) ▲|MMM192.08+15.03 (+8.49%) ▲|MO78.42+1.48 (+1.92%) ▲|MRK148.47+3.80 (+2.63%) ▲|MS191.00+4.91 (+2.64%) ▲|MSFT553.68+32.69 (+6.27%) ▲|MU804.52-50.58 (-5.92%) ▼|NEE88.10+3.77 (+4.47%) ▲|NFLX66.07+2.65 (+4.17%) ▲|NKE40.67+2.19 (+5.68%) ▲|NOW109.90+0.74 (+0.68%) ▲|NVDA202.58-4.11 (-1.99%) ▼|ORCL125.60-0.59 (-0.47%) ▼|PEP143.51+6.24 (+4.55%) ▲|PFE30.52+0.52 (+1.73%) ▲|PG167.56+5.50 (+3.39%) ▲|PLTR171.38-4.02 (-2.29%) ▼|PM211.56+3.53 (+1.70%) ▲|QCOM165.57+1.14 (+0.69%) ▲|RTX195.21-8.61 (-4.22%) ▼|SBUX108.67+3.90 (+3.72%) ▲|SCHW92.63+3.35 (+3.75%) ▲|SO92.27-1.48 (-1.58%) ▼|SPG227.15+5.07 (+2.28%) ▲|T22.00+0.61 (+2.83%) ▲|TMO701.50+3.16 (+0.45%) ▲|TMUS160.11+5.70 (+3.69%) ▲|TSLA382.71-15.79 (-3.96%) ▼|TXN308.07-4.42 (-1.41%) ▼|UBER71.43+4.83 (+7.25%) ▲|UNH404.65+0.21 (+0.05%) ▲|UNP305.39+1.96 (+0.64%) ▲|UPS113.61+4.44 (+4.06%) ▲|USB60.50+0.61 (+1.02%) ▲|V432.75+12.33 (+2.93%) ▲|VZ46.41+1.17 (+2.58%) ▲|WFC86.69+1.16 (+1.35%) ▲|WMT130.01+5.15 (+4.12%) ▲|XOM170.81-6.66 (-3.75%) ▼|
19.7 C
New York
Wednesday, November 4, 2026

Tag: press release

newsFORsourcecompanycontentinformationreleases1market

European Medicines Agency Recommends Market Approval of AVT06, Alvotech’s Proposed Biosimilar to Eylea® (aflibercept)

REYKJAVIK, ICELAND and LONDON, UK (June 23, 2025) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz Pharma, a UK headquartered global pharmaceutical company with a strategic focus on specialty, hospital, and rare disease medicines in Europe, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human use (CHMP) adopted a positive opinion recommending approval for AVT06, Alvotech’s proposed biosimilar to Eylea® (aflibercept 2 mg). Based on a positive recommendation by CHMP, biosimilar medicines can be approved by the European Commission for marketing in the European Economic Area, that includes the 27 member states of the European Union, in addition to Norway, Iceland and Lichtenstein.

New study published in Journal of Experimental Medicine reveals a CARMIL2 mutation with therapeutic antitumor potential

Press Release

Galapagos Appoints Aaron Cox as Chief Financial Officer

Former Horizon CFO joins Galapagos with deep expertise in international corporate finance, M&A, business development and strategic leadership 

DHL’s E-Commerce Trends Report 2025: AI and social media reshaping online shopping in Asia Pacific

Lack of delivery options is the number one conversion killer: 77% of shoppers in Asia Pacific abandon their carts when preferred delivery options are...

Shareholders who own 3D Systems (NYSE: DDD) Should Contact Wolf Haldenstein

NEW YORK, June 22, 2025 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP announces that securities class action lawsuit has been filed in the United States District Court for the District of Delaware on behalf of all persons or entities who purchased or otherwise acquired 3D Systems Corporation (3D Systems or the Company) (NYSE: DDD) securities between August 13, 2024 and May 12, 2025, inclusive (the Class Period).

McLaren Health Care Data Breach Alert Issued By Wolf Haldenstein

PLEASE CLICK HERE TO SUBMIT YOUR CONTACT INFORMATION

Lilly’s once-weekly insulin efsitora alfa demonstrated A1C reduction and a safety profile consistent with daily insulin in multiple Phase 3 trials

Results from the fixed-dose QWINT-1 study, along with the QWINT-3 and QWINT-4 studies, reinforce efsitora's potential to simplify insulin management with weekly dosing Lilly plans...

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of 3D Systems Corporation – DDD

NEW YORK, June 22, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of  3D Systems Corporation ("3D Systems" or the...

Pomerantz Law Firm Announces the Filing of a Class Action Against PepGen Inc. and Certain Officers – PEPG

NEW YORK, June 22, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against PepGen Inc. ("PepGen" or the "Company")...

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PTC Therapeutics, Inc. – PTCT

NEW YORK, June 22, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of PTC Therapeutics, Inc. ("PTC" or the "Company") (NASDAQ: PTCT).  Such...

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeuroPace, Inc. – NPCE

NEW YORK, June 22, 2025 /PRNewswire/ -- APomerantz LLP is investigating claims on behalf of investors of  NeuroPace, Inc. ("NeuroPace" or the "Company") (NASDAQ:...

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rocket Pharmaceuticals, Inc. – RCKT

NEW YORK, June 22, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Rocket Pharmaceuticals, Inc. ("Rocket" or the "Company")...

Jason Yang and Ruoqi Li Featured In XYZ Media’s “Next Generation of Innovators” Series for Developing an AI-Driven Multimodal Model Advancing Elderly Fall Risk...

LOS ANGELES, June 22, 2025 (GLOBE NEWSWIRE) -- XYZ Media, a leading media company that bridges educational pursuits with technological innovation, is proud to announce the latest feature in its “Next Generation of Innovators” series, a digital campaign celebrating extraordinary young minds developing innovative solutions to global challenges. The latest series highlights two exceptional student researchers - Jason Yang of Head-Royce School in Oakland, CA, and Ruoqi Li of The Harker School in San Jose, CA - for their novel work in developing a multimodal machine learning framework that accurately assesses fall risk among the elderly using sensors, video, and contextual data.

Jacob Wang Featured in XYZ Media’s “Next Generation of Innovators” for Developing a Self-Actuated, Eco-Friendly Soft Robot for Drug Delivery

LOS ANGELES, June 22, 2025 (GLOBE NEWSWIRE) -- XYZ Media, a leading media company that bridges educational pursuits with technological innovation, is proud to announce the latest feature in its “Next Generation of Innovators” series, a digital campaign celebrating extraordinary young minds developing innovative solutions to global challenges. The latest series highlights Jacob Wang from Bullis Charter School at Los Altos, CA, for engineering a novel self-actuated soft robot that operates without external power sources or electronics, designed with potential for drug delivery.

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsPress release

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers